Hashimoto Kazuki, Yasumatsu Ryuji, Toh Satoshi, Shiratsuchi Hideki, Yoshida Takamasa, Nishiyama Kazuo, Yoshikawa Hiroshi, Nakashima Torahiko, Nakagawa Takashi
Department of Otolaryngology, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.
Department of Otolaryngology, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.
Auris Nasus Larynx. 2016 Dec;43(6):666-71. doi: 10.1016/j.anl.2016.02.011. Epub 2016 Mar 7.
Eyelid carcinomas are rare, and the management strategy of regional lymph node metastasis linked to eyelid carcinomas has not been standardized to date. The aim of the present study was to analyze the patterns of regional metastasis and to assess the optimal extent of surgical treatment for lymph node metastasis of eyelid carcinoma.
This study was a retrospective review of patient data from a single institution. From a series of 268 eyelid carcinomas, we selected the 21 patients with lymph node metastasis, and we analyzed the patterns of lymphatic spread, approach to treatment and outcomes.
The most common histological type of eyelid carcinoma with regional metastasis was sebaceous carcinoma (17/21, 81.0%). Submandibular area metastases were seen only in the patients with the primary tumor originating in the medial half of the eyelid, but parotid area metastases were seen in both the patients whose tumors had a medial-half origin and those with a lateral-half origin. Although 11 of the 16 patients with parotid-area metastases underwent a tumorectomy or superficial parotidectomy (which resulted in four cases of recurrence in the parotid area), none of the five patients who underwent a total parotidectomy developed parotid-area recurrence. The incidence of regional recurrence of the patients who received adjuvant radiotherapy (14.3%) was lower than that of the patients without adjuvant radiotherapy (57.1%).
Continued surveillance and optimal management of regional lymph node metastases are important for the control and survival of eyelid carcinomas.
眼睑癌较为罕见,迄今为止,与眼睑癌相关的区域淋巴结转移的管理策略尚未标准化。本研究的目的是分析区域转移模式,并评估眼睑癌淋巴结转移的最佳手术治疗范围。
本研究是对来自单一机构的患者数据进行的回顾性分析。在268例眼睑癌患者中,我们选取了21例有淋巴结转移的患者,分析其淋巴扩散模式、治疗方法及预后。
发生区域转移的眼睑癌最常见的组织学类型是皮脂腺癌(17/21,81.0%)。仅在原发肿瘤起源于眼睑内侧半侧的患者中可见下颌下区转移,但在肿瘤起源于内侧半侧和外侧半侧的患者中均可见腮腺区转移。16例发生腮腺区转移的患者中有11例行肿瘤切除术或腮腺浅叶切除术(导致4例腮腺区复发),而5例行腮腺全切除术的患者均未发生腮腺区复发。接受辅助放疗的患者区域复发率(14.3%)低于未接受辅助放疗的患者(57.1%)。
对区域淋巴结转移进行持续监测和优化管理对于眼睑癌的控制和患者生存至关重要。